Photo of Tarek Meniawy
  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 312 Citations
  • 7 h-Index
20102019
If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

Doctor of Philosophy (PhD), The University of Western Australia

Bachelor of Medicine and Bachelor of Surgery (MBBS), Cairo University

External positions

Medical Oncologist, St John of God Subiaco Hospital

Dec 2015 → …

Medical Oncologist, Linear Clinical Research

Apr 2014 → …

Medical Oncologist, Sir Charles Gairdner Hospital

27 Jan 2014 → …

Keywords

  • Medicine and Pharma
  • Gynaecological Cancers
  • Melanoma
  • Clinical Trials
  • Tumour Immunology
  • Immunotherapy

Fingerprint Dive into the research topics where Tarek Meniawy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles
Neoplasms Medicine & Life Sciences
Melanoma Medicine & Life Sciences
DNA Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2019

3 Citations (Scopus)

Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma

Calapre, L., Giardina, T., Robinson, C., Reid, A. L., Al-Ogaili, Z., Pereira, M. R., McEvoy, A. C., Warburton, L., Hayward, N. K., Khattak, M. A., Meniawy, T. M., Millward, M., Amanuel, B., Ziman, M. & Gray, E. S., Feb 2019, In : Molecular Oncology. p. 171-184 14 p.

Research output: Contribution to journalArticle

Open Access
Melanoma
DNA
Mutation
Neoplasms
Biopsy
1 Citation (Scopus)

Monitoring melanoma recurrence with circulating tumor DNA: A proof of concept from three case studies

McEvoy, A. C., Pereira, M. R., Reid, A., Pearce, R., Cowell, L., Al-Ogaili, Z., Khattak, M. A., Millward, M., Meniawy, T. M., Gray, E. S. & Ziman, M., 4 Jan 2019, In : Oncotarget. 10, 2, p. 113-122 10 p.

Research output: Contribution to journalArticle

Open Access
Melanoma
Recurrence
DNA
Neoplasms
Physiologic Monitoring
2 Citations (Scopus)
Open Access
Meta-Analysis
Carcinoma
Drug Therapy
Disease-Free Survival
Biomarkers

A Phase 1B Study of the Anti-PD-1 Monoclonal Antibody, Tislelizumab, in Combination with the Parp Inhibitor, Pamiparib, in Advanced Solid Tumors

Friedlander, M., Meniawy, T., Markman, B., Mileshkin, L. R., Harnett, P., Millward, M., Lundy, J., Freimund, A. E., Norris, C., Wu, J., Paton, V., Wang, L. & Gao, B., Aug 2018, In : Asia-Pacific Journal of Clinical Oncology. 14, p. 58-59 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.

Friedlander, M., Meniawy, T., Markman, B., Mileshkin, L. R., Harnett, P., Millward, M., Lundy, J., Freimund, A. E., Norris, C., Mu, S., Paton, V., Wang, L. & Gao, B., 10 Feb 2018, In : Journal of Clinical Oncology. 36, 5, 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Projects 2015 2016